We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Association between Mucosal Healing and Lipid Profiles in Patients with Ulcerative Colitis: A Cross-Sectional Study.
- Authors
Yagi, Sen; Furukawa, Shinya; Miyake, Teruki; Shiraishi, Kana; Tange, Kazuhiro; Hashimoto, Yu; Kitahata, Shogo; Ninomiya, Tomoyuki; Suzuki, Seiyuu; Shibata, Naozumi; Murakami, Hidehiro; Ohashi, Katsuhisa; Tomida, Hideomi; Yamamoto, Yasunori; Takeshita, Eiji; Ikeda, Yoshio; Hiasa, Yoichi
- Abstract
Introduction: Recent meta-analysis showed that ulcerative colitis (UC) is a risk factor for cardiovascular disease (CVD). Dyslipidemia is a well-established risk factor for CVD. However, evidence regarding inflammatory bowel disease (IBD), including UC and lipid profiles, is limited. Additionally, no study has assessed the association between endoscopic activity and lipid profiles in patients with IBD. Therefore, we aimed to clarify the association between mucosal healing (MH) and lipid profiles in patients with UC. Methods: A total of 221 Japanese patients with UC were enrolled in this analysis. Total cholesterol (T-chol), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) were divided into tertiles (high, moderate, and low) based on the distributions, respectively. Self-administered questionnaire was used to obtain information regarding medication for dyslipidemia. Complete MH and MH are based on Mayo endoscopic subscore 0 and 0–1, respectively. Results: The percentage of complete MH was 30.8%. In patients without medication for dyslipidemia, high HDL-C (>66 mg/dL) was significantly positively associated with complete MH (adjusted odds ratio [OR] 2.58, 95% CI: 1.04–6.64, p for trend = 0.037). In patients with nonproctitis, a positive association between HDL-C and complete MH was found (adjusted OR 3.54, 95% CI: 1.22–11.01, p for trend = 0.020). T-chol and TG were not associated with MH, regardless of medication for dyslipidemia. Conclusions: Complete MH was significantly positively associated with HDL-C in UC patients without medication for lipid. The disease extent might affect the association between complete MH and HDL-C.
- Subjects
ULCERATIVE colitis; HDL cholesterol; INFLAMMATORY bowel diseases; LIPIDS; DISEASE risk factors
- Publication
Digestion, 2023, Vol 104, Issue 2, p129
- ISSN
0012-2823
- Publication type
Article
- DOI
10.1159/000527353